PRKDC and amyotrophic lateral sclerosis: An in vitro study by Monahan et al. (2017), not included in our systematic review, demonstrated that DNA-PK phosphorylates the low complexity domain of FUS, which reduces the formation of aberrant cytosolic aggregates characteristic of ALS-FTD pathology.